MDGS - Medigus under pressure after increasing stake in Polyrizon to ~33%

Medigus ([[MDGS]] -8.0%) after signing an ordinary share purchase agreement to acquire an additional stake in Polyrizon for $0.1M.MDGS currently operates and holds a 19.9% interest in Polyrizon and will own ~33% following the additional investment.Medigus and other Polyrizon shareholders have the option to invest an additional aggregate amount of up to $50K for a period of 60 days after the initial closing.Previously in July 2020, Medigus and Polyrizon had entered into investment and reseller agreements whereby Medigus was granted an exclusive license to resell Polyrizon’s products, focusing on a unique Biogel for protection against COVID-19, the additional investment will advance Polyrizon towards its FDA submission.

For further details see:

Medigus under pressure after increasing stake in Polyrizon to ~33%